Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Schrader

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Antiviral Research|July 30, 2023
Janus kinase-inhibition modulates hepatitis E virus infectionVolker Kinast, Ioana Andreica, Gerrit Ahrenstorf, et al.
Leukemia|April 15, 2025
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemiaAnnika Dechow, Sanna Timonen, Aleksandr Ianevski, et al.
Blood|May 15, 2014
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemiaMark J Kiel, Thirunavukkarasu Velusamy, Delphine Rolland, et al.
The Journal of Pathology|January 23, 2019
Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC-subtype diffuse large B-cell lymphomaMartina Vockerodt, Katerina Vrzalikova, Maha Ibrahim, et al.
Genes, Chromosomes & Cancer|February 26, 2022
T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic levelPaurnima Patil, Sina Hillebrecht, Emil Chteinberg, et al.
Nature Communications|March 10, 2026
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progressionLinus Wahnschaffe, Dennis Jungherz, Tony A Müller, et al.
Genes, Chromosomes & Cancer|November 3, 2019
Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemiaPaurnima Patil, Agata Cieslak, Stephan H Bernhart, et al.
Biomarker Research|October 28, 2020
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemiaCarlos Cuesta-Mateos, Patricia Fuentes, Alexandra Schrader, et al.
Blood|June 28, 2024
Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responsesJana von Jan, Sanna Timonen, Till Braun, et al.
The Journal of Experimental Medicine|April 13, 2016
CD1d-restricted peripheral T cell lymphoma in mice and humansEmmanuel Bachy, Mirjam Urb, Shilpi Chandra, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Antiviral Research|July 30, 2023
Janus kinase-inhibition modulates hepatitis E virus infectionVolker Kinast, Ioana Andreica, Gerrit Ahrenstorf, et al.
Leukemia|April 15, 2025
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemiaAnnika Dechow, Sanna Timonen, Aleksandr Ianevski, et al.
Blood|May 15, 2014
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemiaMark J Kiel, Thirunavukkarasu Velusamy, Delphine Rolland, et al.
The Journal of Pathology|January 23, 2019
Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC-subtype diffuse large B-cell lymphomaMartina Vockerodt, Katerina Vrzalikova, Maha Ibrahim, et al.
Genes, Chromosomes & Cancer|February 26, 2022
T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic levelPaurnima Patil, Sina Hillebrecht, Emil Chteinberg, et al.
Nature Communications|March 10, 2026
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progressionLinus Wahnschaffe, Dennis Jungherz, Tony A Müller, et al.
Genes, Chromosomes & Cancer|November 3, 2019
Reconstruction of rearranged T-cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T-cell prolymphocytic leukemiaPaurnima Patil, Agata Cieslak, Stephan H Bernhart, et al.
Biomarker Research|October 28, 2020
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemiaCarlos Cuesta-Mateos, Patricia Fuentes, Alexandra Schrader, et al.
Blood|June 28, 2024
Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responsesJana von Jan, Sanna Timonen, Till Braun, et al.
The Journal of Experimental Medicine|April 13, 2016
CD1d-restricted peripheral T cell lymphoma in mice and humansEmmanuel Bachy, Mirjam Urb, Shilpi Chandra, et al.
Pageof 3